Skip to main content
. 2018 Jan 29;27(1):30–38. doi: 10.1159/000487236

Table 3.

Attitudes and practices of PV and ADR reporting among physicians and pharmacists working at the polyclinics in Kuwait (n = 485)

Physicians, n = 318 (65.6%) Pharmacists, n = 167 (34.4%) Total,
n = 485 (100%)
p value
Attitude
Which method would you prefer for sending information to an ADR reporting center? 0.680
 E-mail/a website 160 (50.3) 86 (54.1) 246 (51.6)
 Direct contact 103 (32.4) 50 (31.4) 153 (32.1)
 Telephone 37 (11.6) 13 (8.2) 50 (10.5)
 Post 15 (4.7) 7 (4.4) 22 (4.6)
 Other 3 (0.3) 3 (1.9) 6 (1.3)

Practice
Have you ever identified an ADR in any patient? 0.006
 Yes 257 (80.8) 115 (69.7) 372 (77.0)
 No 61 (19.2) 50 (30.3) 111 (23.0)
Number of identified ADR in patients 0.522
 <5 107 (41.6) 47 (42.3) 154 (41.8)
 5–10 74 (28.8) 37 (33.3) 111 (30.2)
 >10 76 (29.6) 27 (24.3) 103 (28.0)
Have you ever reported an ADR? 0.036
 Yes 98 (30.8) 35 (21.7) 133 (27.8)
 No 220 (69.2) 126 (78.3) 346 (72.2)
Are ADR reported as part of “incident reports” at your institution? 0.219
 Yes 79 (24.8) 33 (19.9) 112 (23.1)
 No/I Don't know 239 (75.2) 133 (80.1) 372 (76.9)

Values are expressed as n (%) and may not add up due to missing data. PV, pharmacovigilance; ADR, adverse drug reactions. p values were generated using the Pearson χ2 test.